Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1α muscle-specific knock-out animals

被引:511
作者
Handschin, Christoph
Chin, Sherry
Li, Ping
Liu, Fenfen
Maratos-Flier, Eleftheria
LeBrasseur, Nathan K.
Yan, Zhen
Spiegelman, Bruce M.
机构
[1] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA
[2] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland
[3] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland
[4] Duke Univ, Med Ctr, Dept Med, Durham, NC 27704 USA
[5] Beth Israel Deaconess Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA
[6] Harvard Univ, Sch Med, Boston, MA 02215 USA
[7] Boston Univ, Sch Med, Diabet & Metab Unit, Boston, MA 02118 USA
关键词
D O I
10.1074/jbc.M704817200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The transcriptional coactivator peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) is a key integrator of neuromuscular activity in skeletal muscle. Ectopic expression of PGC-1 alpha in muscle results in increased mitochondrial number and function as well as an increase in oxidative, fatigue-resistant muscle fibers. Whole body PGC-1 alpha knock-out mice have a very complex phenotype but do not have a marked skeletal muscle phenotype. We thus analyzed skeletal muscle-specific PGC-1 alpha knock-out mice to identify a specific role for PGC-1 alpha in skeletal muscle function. These mice exhibit a shift from oxidative type I and IIa toward type IIx and IIb muscle fibers. Moreover, skeletal muscle-specific PGC-1 alpha knock-out animals have reduced endurance capacity and exhibit fiber damage and elevated markers of inflammation following treadmill running. Our data demonstrate a critical role for PGC-1 alpha in maintenance of normal fiber type composition and of muscle fiber integrity following exertion.
引用
收藏
页码:30014 / 30021
页数:8
相关论文
共 31 条
[1]   Transcriptional coactivator PGC-1α controls the energy state and contractile function of cardiac muscle [J].
Arany, Z ;
He, HM ;
Lin, JD ;
Hoyer, K ;
Handschin, C ;
Toka, O ;
Ahmad, F ;
Matsui, T ;
Chin, S ;
Wu, PH ;
Rybkin, II ;
Shelton, JM ;
Manieri, M ;
Cinti, S ;
Schoen, FJ ;
Bassel-Duby, R ;
Rosenzweig, A ;
Ingwall, JS ;
Spiegelman, BM .
CELL METABOLISM, 2005, 1 (04) :259-271
[2]   Signaling pathways in skeletal muscle remodeling [J].
Bassel-Duby, Rhonda ;
Olson, Eric N. .
ANNUAL REVIEW OF BIOCHEMISTRY, 2006, 75 :19-37
[3]   Regulation of peroxisome proliferator-activated receptor γ coactivator 1α (PGC-1α) and mitochondrial function by MEF2 and HDAC5 [J].
Czubryt, MP ;
McAnally, J ;
Fishman, GI ;
Olson, EN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (04) :1711-1716
[4]   Mechanisms of Disease: signaling pathways and immunobiology of inflammatory myopathies [J].
Dalakas, MC .
NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (04) :219-227
[5]   Evidence of oxidative stress in mdx mouse muscle:: Studies of the pre-necrotic state [J].
Disatnik, MH ;
Dhawan, J ;
Yu, Y ;
Beal, MF ;
Whirl, MM ;
Franco, AA ;
Rando, TA .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 161 (01) :77-84
[6]   Control of mitochondrial transcription specificity factors (TFB1M and TFB2M) by nuclear respiratory factors (NRF-1 and NRF-2) and PGC-1 family coactivators [J].
Gleyzer, N ;
Vercauteren, K ;
Scarpulla, RC .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (04) :1354-1366
[7]   Pathogenesis of idiopathic inflammatory myopathies [J].
Grundtman C. ;
Lundberg I.E. .
Current Rheumatology Reports, 2006, 8 (3) :188-195
[8]   Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC-1α [J].
Handschin, C ;
Lin, JD ;
Rhee, J ;
Peyer, AK ;
Chin, S ;
Wu, PH ;
Meyer, UA ;
Spiegelman, BM .
CELL, 2005, 122 (04) :505-515
[9]   An autoregulatory loop controls peroxisome proliferator-activated receptor γ coactivator 1α expression in muscle [J].
Handschin, C ;
Rhee, J ;
Lin, JD ;
Tarr, PT ;
Spiegelman, BM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (12) :7111-7116
[10]  
Handschin C., 2005, Drug Discov. Today Ther. Strateg, V2, P151, DOI [10.1016/j.ddstr.2005.05.001, DOI 10.1016/J.DDSTR.2005.05.001]